Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Trifluridine
Drug ID BADD_D02283
Description Trifluridine is a fluorinated pyrimidine nucleoside that is structurally related to [idoxuridine] [A35271]. It is an active antiviral agent in ophthalmic solutions used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus. It displays effective antiviral activity against Herpes simplex virus type 1 and 2 [A35271]. The combination product of trifluridine with tipiracil marketed as Lonsurf has been approved in Japan, the United States, and the European Union for the treatment of adult patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy. In the anticancer therapy, trifluridine acts as a thymidine-based nucleoside metabolic inhibitor that gets incorporated into DNA of cancer cells following cell uptake to aberrate DNA function during cell replication [F649].
Indications and Usage Ophthalmic solution for the treatment of primay keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2.
Marketing Status Prescription
ATC Code S01AD02
DrugBank ID DB00432
KEGG ID D00391
MeSH ID D014271
PubChem ID 6256
TTD Drug ID D05RHI
NDC Product Code 70225-1108; 59651-388; 76055-0037; 68554-0118; 61314-044; 12785-0004; 54893-0086
Synonyms Trifluridine | Trifluorothymidine | 2'-deoxy-5-(trifluoromethyl)uridine | Trifluoridine | 5-Trifluoromethyl-2'-deoxyuridine | 5 Trifluoromethyl 2' deoxyuridine | Triflumann | Virophta | Viroptic | TFT Ophtiole | Viromidin
Chemical Information
Molecular Formula C10H11F3N2O5
CAS Registry Number 70-00-8
SMILES C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Corneal oedema06.04.02.001--Not Available
Dry eye06.08.02.001--
Eyelid oedema23.04.01.003; 10.01.05.001; 06.04.04.004--Not Available
Hyperaemia24.03.02.002--Not Available
Hypersensitivity10.01.03.003--
Intraocular pressure increased13.07.04.002--Not Available
Keratopathy06.06.03.007--Not Available
Nausea07.01.07.001--
Pain08.01.08.004--
Punctate keratitis06.04.02.003--Not Available
Skin irritation23.03.04.009--Not Available
Vision blurred17.17.01.010; 06.02.06.007--
The 1th Page    1    Total 1 Pages